Reaction Details Report a problem with these data
Target
GTPase KRas
Ligand
BDBM50549220
Substrate
n/a
Meas. Tech.
ChEMBL_2024067 (CHEMBL4677880)
EC50
26600±n/a nM
Citation
 Chen, H; Smaill, JB; Liu, T; Ding, K; Lu, X Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics. J Med Chem 63:14404-14424 (2020) [PubMed]  Article 
Target
Name:
GTPase KRas
Synonyms:
GTPase KRas, N-terminally processed | K-Ras 2 | KRAS | KRAS2 | Ki-Ras | RASK2 | RASK_HUMAN | c-K-ras | c-Ki-ras
Type:
PROTEIN
Mol. Mass.:
21656.10
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1476955
Residue:
189
Sequence:
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM
  
Inhibitor
Name:
BDBM50549220
Synonyms:
CHEMBL4795772
Type:
Small organic molecule
Emp. Form.:
C25H44ClN7O13P2
Mol. Mass.:
748.056
SMILES:
CCCC(CCC)COC(=O)[C@@H](C)NP(=O)(OCCNC(=O)CCl)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2C1N=C(N)NC2=O |r,c:39,t:44|
Structure:
Search PDB for entries with ligand similarity: